Access cutting-edge migraine treatment through this clinical trial at a research site in Lexington. Study-provided care at no cost to qualified participants.
Access migraine specialists in Lexington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related migraine treatment provided free
The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.
Sponsor: H. Lundbeck A/S
Check if you qualify for this migraine clinical trial in Lexington, KY
If you're searching for migraine treatment options in Lexington, KY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lexington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.